Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06963034 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | Clinical Trial |
| Target Enrollment | 284 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06963034 is currently recruiting participants. This clinical trial study for schizophrenia is actively seeking new participants at 16 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06963034 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06963034 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.